Evaluation of an internal cyclotron target for the production of 211At via the 209Bi (α,2n)211At reaction
- 1 February 1996
- journal article
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 47 (2), 135-143
- https://doi.org/10.1016/0969-8043(95)00285-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- α-Particle Radiotherapy with 211At-Labeled Monodisperse Polymer Particles, 211At-Labeled IgG Proteins, and Free 211At in a Murine Intraperitoneal Tumor ModelGynecologic Oncology, 1995
- Preparation and quality control of 211At‐labelled and 125I‐labelled monoclonal antibodies. Biodistribution in mice carrying human osteosarcoma xenograftsJournal of Labelled Compounds and Radiopharmaceuticals, 1994
- Analysis of the therapeutic gain in the treatment of human osteosarcoma microcolonies in vitro with 211At-labelled monoclonal antibodyBritish Journal of Cancer, 1994
- The development of a [211at]-astatinated endoradiotherapeutic drug: Part II. Therapeutic results for transplanted adenocarcinoma of the rectum in mice and associated studiesInternational Journal of Radiation Oncology*Biology*Physics, 1994
- 211At‐labelling of polymer particles for radiotherapy: Synthesis, purification and stabilityJournal of Labelled Compounds and Radiopharmaceuticals, 1993
- A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Cyclotron isotopes and radiopharmaceuticals—XXXV astatine-211The International Journal of Applied Radiation and Isotopes, 1985
- Preparation of a biologically stable and immunogenically competent astatinated proteinInternational Journal of Nuclear Medicine and Biology, 1977
- Excitation Functions of Bismuth and LeadPhysical Review B, 1959
- Artificially Radioactive Element 85Physical Review B, 1940